Jefferies Upgrades Aegerion Pharma To Buy, Sees Positively Skewed Risk/Reward
July 28, 2015 at 08:33 AM EDT
In a report published Tuesday, Jefferies analyst Eun K. Yang upgraded the rating on Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) ...